本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

18.38
-0.4900-2.60%
成交量:20.49萬
成交額:380.98萬
市值:20.40億
市盈率:-11.47
高:18.94
開:18.85
低:18.36
收:18.87
52周最高:44.34
52周最低:15.96
股本:1.11億
流通股本:1.09億
量比:0.83
換手率:0.19%
股息:- -
股息率:- -
每股收益(TTM):-1.6026
每股收益(LYR):-1.6026
淨資產收益率:-22.56%
總資產收益率:-12.16%
市淨率:2.85
市盈率(LYR):-11.47

資料載入中...

2025/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/19

SEC問詢函

Form CORRESP - Correspondence
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities